Contract 75A50322F80018
Partner Therapeutics, Inc. · Department Of Health And Human Services · July 25, 2022
Partner Therapeutics, Inc. was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on July 25, 2022 for $59.03 million of work in pharmaceutical preparation manufacturing. Performance is in Boston, MA. This is a task or delivery order issued under parent IDIQ 36F79718D0593. The contract has been modified 4 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 18, 2024.
Contract details
- PIID
- 75A50322F80018
- Parent IDIQ
- 36F79718D0593
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Boston, MA
- First action
- July 25, 2022
- Latest action
- March 18, 2024
Description
12-MONTH DO TO OBTAIN LEUKINE 250MCG/VIL INJ
Modification timeline
-
March 18, 2024Mod P00004$0
-
December 12, 2023Mod P00003$0
-
July 12, 2023Mod P00002$0
-
August 10, 2022Mod P00001$0
-
July 25, 2022Base awardLEUKINE 250MCG/VIL INJ$59.03M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Sanofi Vaccines Us Inc. | Department Of Health And Human Services | March 27, 2026 | $92.33M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50322F80018?
Contract 75A50322F80018 is a federal contract awarded to Partner Therapeutics, Inc. by Department Of Health And Human Services on July 25, 2022 for $59.03 million of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 4 times since the base award.
Who won contract 75A50322F80018?
Partner Therapeutics, Inc. won contract 75A50322F80018 from Department Of Health And Human Services.
How much is contract 75A50322F80018 worth?
Contract 75A50322F80018 has obligated $59.03 million to date.